Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Vorasidenib Formulations and Effect of Food/Omeprazole
NCT04128787Phase 1Completed
- Sponsor
- Agios Pharmaceuticals
- Start
- Sep 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vorasidenib in glioma (3 arms), sponsored by Agios Pharmaceuticals. Primary endpoints: Area Under the Concentration-Time Curve From Time 0 to Last Observed Non-Zero Concentration, Area Under the Concentration-Time Curve From Time 0 Extrapolated to Infinity and 7 more. Started Sep 2019; status: completed.
02
Drugs
vorasidenib
03
Conditions
glioma
Beyond the preview
Go deeper on NCT04128787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04128787.